Preventive Care vs. Emergency Care: Where Does the Money Go?
The United States will spend an estimated $5.62 trillion on healthcare in 2025 — yet the share reaching preventive services remains smaller than what flows into emergency departments. This analysis maps the full spending landscape, compares the two categories head-to-head, and examines what the imbalance means for long-term health outcomes and fiscal sustainability.
Methodology
All spending figures are analytical estimates derived from official U.S. and international datasets. They are harmonised to provide a consistent 2025 comparison across major spending categories and should be read as directional estimates rather than final settled accounts.
2023 actuals (CMS NHE) projected forward to 2025 using CMS growth path from the 2023–2032 NHE Projections report.
Derived from CMS projections: $4.87T (2022 actual) × compound annual growth rate of ~5.6% to reach ~$5.62T for 2025.
HCUP emergency department cost data for 2017 are used as the empirical base and projected forward with a mid-single-digit growth assumption to reach an estimated 2025 level of about $220B. The result is cross-checked against broader CMS hospital outpatient spending trends.
OECD/Peterson-KFF data show preventive & public health spending at 2.9% of total U.S. health expenditure (2018, latest comparable year). Applied to 2025 NHE total: 2.9% × $5,620B ≈ $163B.
Category-level growth rates are harmonised estimates combining CMS sub-account projections and sector-specific trend analysis. All figures rounded to one decimal place.
ED spending sometimes overlaps with hospital outpatient figures depending on how costs are booked. Preventive spending likely understates public-health infrastructure spending at state level. Both figures are estimates; official NHE account data lag by 18–24 months.
The full landscape of U.S. healthcare spending in 2025
Emergency departments and preventive programs together account for less than 7% of national health expenditure. The bulk of the healthcare dollar flows to physician and clinical services (~18%), hospital inpatient care (~16%), and prescription drugs (~14%). Understanding where ED and prevention sit within the total picture is essential context for any policy conversation about reallocation.
The table below covers all 14 major NHE categories. Use the search field, type filter, or row selector to explore the data. Toggle the Units / Share button to switch between dollar amounts and percentage of total NHE. Total U.S. NHE in this 2025 estimate: $5,620 billion.
Table 1. U.S. National Health Expenditure by Category, 2025 estimate
| # | Category | 2025 est. ($B) ▼ | YoY % | % of NHE | Type |
|---|---|---|---|---|---|
| 1 | Physician & Clinical Services | 1,005 17.88% | +5.8% | 17.9% | Clinical |
| 2 | Hospital Inpatient Care | 880 15.66% | +5.2% | 15.7% | Clinical |
| 3 | Prescription Drugs (Retail) | 760 13.52% | +7.2% | 13.5% | Pharma |
| 4 | Hospital Outpatient Care | 695 12.37% | +6.1% | 12.4% | Clinical |
| 5 | Long-Term Care | 435 7.74% | +4.8% | 7.7% | Long-term |
| 6 | Other Health Services | 372 6.62% | +4.9% | 6.6% | Other |
| 7 | Mental Health & Substance Use | 290 5.16% | +6.4% | 5.2% | Clinical |
| 8 | Emergency Department Services | 220 3.91% | +5.4% | 3.9% | Emergency |
| 9 | Admin & Net Insurance Cost | 215 3.83% | +4.7% | 3.8% | Admin |
| 10 | Dental Services | 188 3.35% | +4.2% | 3.3% | Clinical |
| 11 | Preventive Care & Public Health | 163 2.90% | +3.1% | 2.9% | Preventive |
| 12 | Home Health Care | 157 2.79% | +5.9% | 2.8% | Clinical |
| 13 | Medical Equipment & Supplies | 142 2.53% | +4.5% | 2.5% | Other |
| 14 | Research & Public Health Programs | 98 1.74% | +2.8% | 1.7% | Preventive |
Sources: CMS National Health Expenditure Projections 2023–2032; HCUP Statistical Brief #268; OECD Health Statistics via Peterson-KFF Health System Tracker. All values are analytical estimates rounded to the nearest billion.
Chart 1. Preventive Care vs. Emergency Services — context within NHE (2025 est.)
The bar chart shows the two focus categories alongside the largest NHE accounts for scale context. Dollar values in billions (USD).
Highlighted bars: ■ Preventive Care ■ Emergency Dept. — all other categories in grey for context. Values are estimates; source: CMS NHE Projections 2023–2032, HCUP, OECD.
Insights and analytical findings
1. A reactive system at scale
The U.S. healthcare system's spending hierarchy is structurally oriented toward treatment of established illness rather than prevention of its onset. Physician and clinical services, inpatient care, and prescription drugs — all primarily reactive in function — collectively absorb nearly 46% of NHE. By contrast, preventive care and public health research combined account for roughly 4.6% of NHE. That is only modestly above the administrative overhead of the insurance system (~3.8%) and still small relative to the major treatment-centered categories that dominate the spending hierarchy.
This is not unique to 2025: OECD data show that the U.S. preventive spending share has actually declined from 3.7% of health expenditure in 2000 to approximately 2.9% in recent years, even as total spending per person has more than doubled in real terms. The gap is widening in absolute dollar terms even as the relative share shrinks.
2. The emergency department as a structural cost amplifier
Emergency department spending — estimated at $220 billion in 2025 — grew at roughly 5.4% annually over the preceding decade, outpacing inflation and population growth. Three structural factors drive this:
- Non-urgent utilisation. Between one-third and one-half of all ED visits in the U.S. are classified as non-urgent or primary-care-treatable, according to repeated HCUP analyses. These visits cost 5–10 times more per episode than equivalent primary or urgent-care encounters.
- Safety-net function. EDs are legally required to provide stabilising treatment regardless of insurance status or ability to pay (EMTALA, 1986). Uncompensated care costs are partially shifted to insured payers, contributing to higher average per-visit charges ($2,700–$3,100 for the uninsured in 2023).
- Chronic disease burden. The CDC estimates that 6 in 10 American adults have at least one chronic disease. Many emergency presentations — hypertensive crisis, diabetic ketoacidosis, advanced heart failure — are the direct downstream consequence of under-managed chronic conditions that preventive and primary care could have intercepted earlier.
3. The return on preventive investment
A 2023 review in the American Journal of Preventive Medicine synthesised findings from over 40 cost-benefit analyses of U.S. preventive interventions. Median return on investment for evidence-based community prevention programmes was $5.70 per dollar spent over a five-year horizon — a figure consistent with the earlier Trust for America's Health estimate of $5.60 for tobacco, nutrition and physical activity programmes. However, these returns are typically realised over 5–15 year windows, creating a mismatch with annual budget cycles and political incentive structures.
Specific interventions with documented cost-effectiveness include childhood vaccination (every dollar invested in routine vaccination programmes is estimated to return $3–$11 in averted treatment costs), colorectal cancer screening, blood pressure control in hypertensive patients, and structured diabetes prevention programmes. The ACA's mandate for first-dollar preventive coverage has improved utilisation, but rural access gaps, administrative complexity and low-health-literacy populations continue to constrain reach.
4. The prescription drug wildcard
At $760 billion and growing at 7.2% annually — the fastest growth rate of any major NHE category — prescription drug spending is now the third-largest cost driver in U.S. healthcare. A significant share of this spending is on medicines for chronic conditions that are in principle preventable or delayable. The fastest-growing sub-segment, GLP-1 receptor agonists (semaglutide, tirzepatide), straddles the boundary between treatment and prevention: used both to manage type 2 diabetes and obesity and, in emerging clinical evidence, to reduce cardiovascular events. How this class is classified and reimbursed will materially affect the preventive vs. treatment split in future years.
Bottom line: The $57 billion gap between emergency and preventive spending is not merely a budgeting anomaly — it reflects a system that is structurally incentivised to pay for crisis rather than invest in health. Shifting even 1 percentage point of NHE from reactive to preventive spending would represent $56 billion in reallocation — more than the entire current preventive care budget — with evidence-based potential to reduce ED demand, chronic disease burden and long-term fiscal pressure.
What this means for you
Healthcare spending statistics can feel abstract, but the preventive-vs.-emergency gap has direct consequences for individuals, families and employers.
- If you have employer-sponsored insurance: Since the Affordable Care Act, most private plans are required to cover a defined list of preventive services — annual wellness visits, cancer screenings, immunisations, contraception — without any cost-sharing. Many people are unaware that these services are free at the point of care. Using them costs you nothing out of pocket and reduces the chance of a far more expensive emergency episode later.
- If you are uninsured or underinsured: Federally Qualified Health Centers (FQHCs) operate on a sliding-fee scale and provide preventive, primary and dental care regardless of insurance status. The HRSA health center finder (findahealthcenter.hrsa.gov) lists over 1,400 centres nationwide. A primary-care visit at an FQHC typically costs $20–40; a non-urgent ED visit for the same complaint can exceed $1,500.
- If you are an employer: The business case for employee preventive care is well documented. The CDC's Workplace Health Promotion framework cites median return on investment of $3.27 for every dollar spent on workplace wellness programmes, driven primarily by reduced absenteeism and avoided emergency or inpatient costs for manageable conditions.
- If you follow health policy: The spending numbers in this analysis will be used in congressional budget debates over Medicaid expansion, Medicare preventive-benefit structure and public-health appropriations. The core tension — that prevention saves money in the long run but requires upfront spending that does not show returns within a budget year — is the central political obstacle to rebalancing the system.
Key takeaway: The most cost-effective thing most Americans can do for their health and their wallet is to use the preventive services already covered at zero cost under their insurance plan — and to seek primary care for non-urgent conditions rather than defaulting to emergency departments.
FAQ
Why does the U.S. spend so much on healthcare but rank poorly on outcomes like life expectancy?
The U.S. spends roughly twice the OECD average per person on healthcare but ranks near the bottom of high-income countries on life expectancy, avoidable mortality and infant mortality. The primary reasons are structural: a heavy tilt toward high-cost curative and acute care, fragmented insurance coverage, high administrative overhead (almost 4% of NHE), high drug prices, and under-investment in the social determinants of health — housing, nutrition, education — which account for 40–60% of health outcomes but lie mostly outside the health system budget.
Is emergency care always more expensive than the equivalent preventive intervention?
For conditions with effective prevention pathways, yes — dramatically so. Managing hypertension with medication and lifestyle guidance costs hundreds of dollars per year; hospitalisation for a hypertension-related stroke costs $20,000–$60,000. However, not all emergency spending is preventable. Trauma, acute infections and congenital conditions require emergency response regardless of preventive coverage. Analysts estimate that roughly 25–35% of current ED spending could be displaced by adequate access to primary and preventive care.
What exactly is counted as "preventive care" in these figures?
The OECD/WHO definition used in these estimates includes: organised immunisation and screening programmes, public-health surveillance and disease control, health promotion and education campaigns, and early-detection services such as mammography, colonoscopy and cervical screening. It does not include the full cost of managing chronic conditions, even where those conditions could have been prevented. This narrow definition is one reason the 2.9% share looks so small — much prevention embedded within primary care visits is counted under physician services instead.
Will GLP-1 drugs change the balance between treatment and prevention costs?
Possibly, but the net effect is uncertain. GLP-1 receptor agonists (semaglutide, tirzepatide) reduce body weight, blood sugar, blood pressure and cardiovascular events — outcomes that typically generate large downstream savings in hospitalisation and chronic disease management. However, at current list prices ($10,000–$14,000 per patient per year), widespread adoption would add substantially to the prescription drug budget before any downstream savings materialise. Budget models suggest net savings only if adherence is high and prescribing is targeted to high-risk populations.
How does the U.S. preventive care share compare to other wealthy countries?
OECD data show most Western European countries allocating 3–5% of health spending to prevention and public health, with some Nordic countries exceeding 5%. The U.S. figure of ~2.9% is below the OECD average and has been declining in relative terms since 2000. Countries with stronger preventive orientations — Germany, Japan, Australia — also tend to have lower age-standardised rates of preventable hospitalisation and longer healthy life expectancy.
Could the figures in this article be different from other estimates I've seen?
Yes, and that is expected. The boundaries between NHE categories vary by methodology. Some sources include preventive medications (statins, aspirin) under prevention; others do not. HCUP ED cost estimates capture billed charges rather than paid amounts, inflating raw figures. CMS NHE accounts use site-of-service coding that may not align with functional categories. All numbers in this article are estimates intended to convey order of magnitude and relative scale, not audit-grade statistics. For formal policy work, consult the primary CMS NHE tables directly.
Primary data sources and technical notes
All estimates draw on publicly accessible official or peer-reviewed datasets. Figures are harmonised and rounded for analytical comparability. For authoritative statistics, consult the primary sources below.
CMS — National Health Expenditure Projections 2023–2032
The primary source for total NHE, category-level sub-accounts, and growth projections used to derive 2025 estimates.
cms.gov — NHE ProjectionsHCUP — Costs of Emergency Department Visits, 2017 (Statistical Brief #268)
Provides the empirical base for ED cost estimates, including aggregate billed amounts and per-visit averages used to project 2025 figures.
hcup-us.ahrq.gov — Statistical Brief #268Peterson-KFF Health System Tracker — Public Health Spending
OECD-sourced analysis of U.S. preventive care as a share of total health spending, used to derive the 2.9% ratio applied to 2025 NHE.
healthsystemtracker.org — Public Health SpendingCDC — FastStats: Emergency Department
Provides annual ED utilisation data (visit volumes, chief complaint mix) used to assess the non-urgent visit share.
cdc.gov — FastStats: Emergency DepartmentHealthcare.gov — Preventive Care Benefits
Official listing of ACA-mandated preventive services covered without cost-sharing under most private insurance plans.
healthcare.gov — Preventive Care BenefitsCMS — Preventive Care Background (CCIIO)
Policy and regulatory context for ACA preventive care mandates, including the chronic-disease cost share cited in the analysis.
cms.gov — Preventive Care BackgroundOECD Health Statistics
International comparison data for preventive care spending shares across OECD member states, used for context in the FAQ section.
oecd.org — Health StatisticsAll numerical values are estimates. Rounding applied throughout. For formal statistical or policy work, always consult original databases and accompanying methodological documentation.
